Dominant effector genetics in mammalian cells

被引:81
作者
Xu, X [1 ]
Leo, C
Jang, YJ
Chan, E
Padilla, D
Huang, BCB
Lin, T
Gururaja, T
Hitoshi, Y
Lorens, JB
Anderson, DC
Sikic, B
Luo, Y
Payan, DG
Nolan, GP
机构
[1] Rigel Inc, San Francisco, CA USA
[2] Stanford Univ, Dept Microbiol & Immunol, Dept Mol Pharmacol, Palo Alto, CA 94304 USA
[3] Stanford Univ, Dept Med Oncol, Palo Alto, CA 94304 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/83717
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have expressed libraries of peptides in mammalian cells to select for trans-dominant effects on intracellular signaling systems. As an example-and to reveal pharmacologically relevant points in pathways that lead to Taxol resistance-we selected for peptide motifs that confer resistance to Taxol-induced cell death. Of several peptides selected, one, termed RGP8.5, was linked to upregulation of expression of the gene ABCB1 (also known as MDR1, for multiple drug resistance) in HeLa cells. Our data indicate that trans-dominant effector peptides can point to potential mechanisms by which signaling systems operate. Such tools may be useful in functional genomic analysis of signaling pathways in mammalian disease processes.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 48 条
  • [1] [Anonymous], CURRENT PROTOCOLS MO
  • [2] EXPRESSION AND FUNCTION OF P-GLYCOPROTEIN IN HUMAN MESANGIAL CELLS
    BELLOREUSS, E
    ERNEST, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1994, 267 (05): : C1351 - C1358
  • [3] Isolation of peptide aptamers that inhibit intracellular processes
    Blum, JH
    Dove, SL
    Hochschild, A
    Mekalanos, JJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (05) : 2241 - 2246
  • [4] THE NEUROPEPTIDE HEAD ACTIVATOR LOSES ITS BIOLOGICAL-ACTIVITY BY DIMERIZATION
    BODENMULLER, H
    SCHILLING, E
    ZACHMANN, B
    SCHALLER, HC
    [J]. EMBO JOURNAL, 1986, 5 (08) : 1825 - 1829
  • [5] The basic structure of filamentous phage and its use in the display of combinatorial peptide libraries
    Cabilly, S
    [J]. MOLECULAR BIOTECHNOLOGY, 1999, 12 (02) : 143 - 148
  • [6] Transdominant genetic analysis of a growth control pathway
    Caponigro, G
    Abedi, MR
    Hurlburt, AP
    Maxfield, A
    Judd, W
    Kamb, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) : 7508 - 7513
  • [7] CASTRO B, 1975, TETRAHEDRON LETT, V14, P1219
  • [8] Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins
    Chen, G
    Duran, GE
    Steger, KA
    Lacayo, NJ
    Jaffrezou, JP
    Dumontet, C
    Sikic, BI
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (09) : 5974 - 5982
  • [9] SIGNAL-INDUCED SITE-SPECIFIC PHOSPHORYLATION TARGETS I-KAPPA-B-ALPHA TO THE UBIQUITIN-PROTEASOME PATHWAY
    CHEN, ZJ
    HAGLER, J
    PALOMBELLA, VJ
    MELANDRI, F
    SCHERER, D
    BALLARD, D
    MANIATIS, T
    [J]. GENES & DEVELOPMENT, 1995, 9 (13) : 1586 - 1597
  • [10] Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2
    Colas, P
    Cohen, B
    Jessen, T
    Grishina, I
    McCoy, J
    Brent, R
    [J]. NATURE, 1996, 380 (6574) : 548 - 550